Approximately 10% women are thought to be affected with endometriosis. An understanding of its pathogenesis seems to be rather poor, though the scale of the problem is large. Limited to conventional hormonal therapies and surgical intervention, women usually suffer from adverse effects that make the disease even more psychically and psychologically debilitating. Recent advances in the field of discovering endometriosis’ etiology lead to surprising findings. The underestimated potential of statins gives hope for their application in endometriosis treatment. New selective estrogen modulators might also come in handy. What is more, the greater insight into the role of stem cells in development of endometrial lesions may result in therapy targets that no one ever thought of. Read full text »